跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 26,601 条关于
“Hunan Siweikang Therapeutics”
全部
26,601
临床试验
12,017
药物
4,223
机构
1,169
资讯
9,192
去年
Novel CAR T-Cell Therapy SCAR-02 Shows Promise for Multiple Autoimmune Conditions
8个月前
WORK Medical Receives Regulatory Approval for AI-Powered Blood Cell Morphology Analyzer
8个月前
Novartis Acquires Chinese Biotech's Radioligand Therapy Asset in $50 Million Deal
3个月前
China Approves First Class 3.1 Classical Formula Drug Zhenwu Tang Granules, Marking TCM Modernization Milestone
去年
Ivonescimab Plus Chemotherapy Shows Promising 80% Response Rate in Advanced Triple-Negative Breast Cancer Trial
6个月前
Junshi Biosciences Achieves Regulatory Milestone with First Domestic Subcutaneous Anti-PD-1 Antibody Application in China
去年
LakeShore Biopharma Launches First Needle-Free Rabies Vaccine Reconstitution System in China
8个月前
Acuitas Therapeutics Acquires Majority Stake in RNA Technologies & Therapeutics to Advance RNA-LNP Therapeutics
2个月前
China Expands Personalized Cosmetic Service Pilot to 23 Provincial-Level Regions
去年
Pheno Therapeutics' PTD802 Receives MHRA Approval for MS Clinical Trial
第 1 页，共 920 页
上一页
下一页
